3 completed, 1 not yet recruiting. 3 Phase 4, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Vildagliptin (Galvus): new trials by email Literature Review of Vildagliptin (Galvus) trials Research Report on Vildagliptin (Galvus)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Vildagliptin Versus Metformin in Patients With Polycystic Ovary Syndrome Metformin, Vildagliptin (Galvus) - Poly Cystic Ovary Syndrome | Phase 2 / Phase 3 | Not yet recruiting | Tanta University | 70 | 2026-09-20 | 2026-09-21 |
| Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. Metformin, Dulaglutide, Semaglutide 1.0 mg - Diabetes Mellitus Type 2 | Phase 4 | Completed | Fundación para la Investigación del Hospital Clínico de Valencia | 92 | 2025-05-26 | 2026-09-04 |
| A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM Vildagliptin (Galvus), Insulin - Haemodialyzed, Type 2 Diabetes | Phase 4 | Completed | University Hospital, Strasbourg, France | 70 | 2014-06-01 | 2026-03-16 |
| Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women Vildagliptin - 1- Microvascular Function, 2-oxidative Stress | Phase 4 | Completed | Rio de Janeiro State University | 40 | 2013-04-01 | 2017-05-31 |
Diabetes Mellitus, Type 2 (2) · Diabetes Mellitus (1) · Hyperglycemia (1) · Hypoglycemia (1)
Fundación para la Investigación del Hospital Clínico de Valencia (1) · Rio de Janeiro State University (1) · Tanta University (1) · University Hospital, Strasbourg, France (1)
Brazil (1) · France (1) · Spain (1)
2025 (1)